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Routine Testing for Anaerobic Bacteria in Cerebrospinal Fluid
Cultures Improves Recovery of Clinically Significant Pathogens
Meredith E. Pittman,a Benjamin S. Thomas,b Meghan A. Wallace,a Carol J. Weber,c Carey-Ann D. Burnhama
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USAa; Division of Infectious Diseases, Washington University
School of Medicine, St. Louis, Missouri, USAb; Department of Laboratories, Barnes Jewish Hospital, St. Louis, Missouri, USAc
In North America, the widespread use of vaccines targeting Haemophilus influenzae type b and Streptococcus pneumoniae have
dramatically altered the epidemiology of bacterial meningitis, while the methodology for culturing cerebrospinal fluid (CSF)
specimens has remained largely unchanged. The aims of this study were 2-fold: to document the current epidemiology of bacte-
rial meningitis at a tertiary care medical center and to assess the clinical utility of routinely querying for anaerobes in CSF cul-
tures. To that end, we assessed CSF cultures submitted over a 2-year period. A brucella blood agar (BBA) plate, incubated anaer-
obically for 5 days, was included in the culture procedure for all CSF specimens during the second year of evaluation. In the pre-
and postimplementation years, 2,353 and 2,302 CSF specimens were cultured, with 49 and 99 patients having positive culture
results, respectively. The clinical and laboratory data for patients with positive cultures were reviewed. Anaerobic bacteria were
isolated in the CSF samples from 33 patients post-BBA compared to two patients pre-BBA (P 0.01). The anaerobic isolates in-
cluded Bacteroides thetaiotaomicron (n 1), Propionibacterium species (n 15), and Propionibacterium acnes (n 19) iso-
lates; all of these isolates were recovered on the BBA. Eight of the 35 patients fromwhom anaerobic organisms were isolated re-
ceived antimicrobial therapy. Although six of these patients had central nervous system hardware, two patients did not have a
history of a neurosurgical procedure and had community-acquired anaerobic bacterial meningitis. This study demonstrates that
the simple addition of an anaerobically incubated BBA to the culture of CSF specimens enhances the recovery of clinically signif-
icant anaerobic pathogens.
The epidemiology of bacterial meningitis in developed countrieshaschangeddramaticallyover the last3decades.As recentlyas the
1980s in theUnitedStates, threepathogens,Haemophilus influenzae,
Streptococcus pneumoniae, and Neisseria meningitidis, accounted
for 80% of community-acquired bacterial meningitis cases (1,
2).With the introduction of vaccines directed atH. influenzae type
b, S. pneumoniae, and N. meningitis, a dramatic decline has oc-
curred in the rate of central nervous system infection caused by
these organisms.
The contemporaneous emergence of immunocompromised
patient populations and increasing antimicrobial resistance in
bacterial pathogens has further contributed to the evolution of
this disease. Patients with chronic diseases and/or chronic immu-
nosuppression are living longer and are susceptible to infections
caused by pathogens typically thought to be of low virulence (3, 4).
Additionally, patients who undergo neurosurgical procedures or
have ventriculoperitoneal shunts in place are at high risk for sub-
sequent infection. The rates of infection are reported to be as high
as 11 to 18% per patient after initial shunt placement (5, 6).
The protocols used by clinical microbiology laboratories for
the culture of cerebrospinal fluid (CSF) specimens have been rel-
atively static for many decades. Although attempts have been
made to develop sophisticated assays to detect bacterial patho-
gens, these tests have not been shown to improve upon bacterial
culture (7–10). The mainstay of CSF culture remains the inocula-
tion of specimens to blood and chocolate agar plates and incuba-
tion at 35°C in an environment with 5% CO2 (11). As a result of
the altered landscape of bacterial meningitis, now is the ideal time
for a reevaluation of culture methods for CSF specimens.
The objectives of this study were to evaluate the current epide-
miology of pathogenic organisms recovered from CSF cultures at
a tertiary care academic medical center and to evaluate the impact
of adding a single piece of medium, incubated anaerobically, on
the recovery of anaerobic organisms that are clinically relevant in
the contemporary era of bacterial meningitis.
MATERIALS AND METHODS
Laboratory methods. Cytospin Gram stains were prepared on all CSF
specimens submitted to the laboratory. If 2 ml of CSF was received by
the laboratory, the specimen was centrifuged and the sediment was inoc-
ulated onto solid agar. Prior to 3 January 2012, all CSF specimens submit-
ted to the Barnes-Jewish Hospital microbiology laboratory for bacterial
culture were inoculated onto sheep blood agar (SBA) and chocolate agar
(Remel, Lenexa, KS) and incubated in 5% CO2 for a minimum of 48 h to
observe for growth. After 3 January 2012, a prereduced brucella blood
agar (BBA) plate (Hardy Diagnostics, SantaMaria, CA), incubated anaer-
obically, was added to the standard CSF specimen protocol. The BBA agar
is routinely held for 48 h prior to being examined, and the anaerobic
medium is held for a total of 5 days to observe for growth. Any organism
recovered in culture was identified according to the laboratory standard
operating procedures, typically involving a combination of Gram stain-
ing, spot tests, and phenotypic profiling.
Data collection. The microbiology laboratory database was queried
for all CSF cultures submitted within 1 year prior to and 1 year following
the introduction of BBA. All positive CSF cultures were linked with pa-
tient data collected from the electronic medical record, including patient
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history, presenting symptoms, culture results, patient outcome, and dis-
charge diagnoses as enumerated in the physician discharge summary. Pa-
tients with more than one CSF culture submitted per visit had all positive
culture results reviewed. For patients whose initial positive culture result
matched those of the subsequent cultures, the initial culture result was
utilized in statistical analyses. For the three patients whose subsequent
culture results differed from those of the initial cultures (n  6), the
culture considered to be most clinically significant (see Results) was used
in the statistical analysis.
The clinical significance of the recovery of an organism in culture was
inferred from the decision of the clinicians to initiate or continue treat-
ment with antimicrobials once the culture results became available. If
empirical antimicrobials had been given but were stopped at the time of
culture results, these patients were not considered to be treated for men-
ingitis. As a separate but related measure of clinical significance, an infec-
tious diseases specialist, blinded to actual treatment course, performed an
independent review of presenting symptoms, medical comorbidities, CSF
profile, and CSF culture results and gave a retrospective treatment recom-
mendation. Thus, the clinical significance of the isolates recovered in cul-
ture was determined both prospectively and retrospectively by medical
professionals.
Statistical analysis. Student’s t test orMann-Whitney U test for inde-
pendent samples were used to compare the means and distributions of
patient populations for the appropriate parametric data or nonparametric
data, respectively. Chi-square or Fisher’s exact tests were used to describe
categorical differences between the patient populations and culture re-
sults. A kappa statistic was calculated for the agreement between the pro-
spective and retrospective evaluations of clinical significance of the iso-
lates recovered in culture. Statistical analyses were performed using SPSS
Statistics version 20 software (IBM Corp., Armonk, NY).
RESULTS
Patient population. In the 12 months prior to the BBA addition,
2,352 CSF specimens were submitted to the laboratory for bacte-
rial culture, resulting in 69 positive cultures (2.9%) from 49 pa-
tients. In the 12 months following the addition of the BBA, 2,302
CSF specimens were submitted for bacterial culture, resulting in
113 positive cultures (4.9%) from 99 patients, a statistically signif-
icant difference in positive culture results (P  0.001). A sample
from one patient was present in both the pre- and the post-BBA
data, but all other patient samples were unique. The demographic
and clinical characteristics of the 148 patients with positive CSF
cultures are presented in Table 1. During both of the time periods
evaluated, the patient populations were similar with regard to
their presenting symptoms and discharge diagnoses. Additionally,
the number of patients whowere immunosuppressed (45 [30.2%]
overall) and who had central nervous system hardware (39
[26.2%] overall) did not vary between the groups. Of interest, the
patients in the pre-BBA year were more likely to have recently
(within 90 days) had a surgical procedure (42.9%; P  0.004),
although the difference between those with neurosurgical and
nonneurosurgical procedures was not statistically different (P 
0.4).
Culture results.Onehundredfifty-one isolateswere recovered
over the study period from 148 patients (Table 2). Of these, only
eight (0.5%) of the pathogens recovered were what would be con-
sidered “classic” pathogens in bacterial meningitis. One culture
grew H. influenzae, one culture grew N. meningitidis (group B),
and six cultures grew S. pneumoniae.
The majority of patients evaluated in this study had only one
positive CSF culture result. Eighteen patients had more than one
positive CSF culture result (n  52) during a single period of
illness. For 15 of these patients, the subsequent culture result
matched the original culture result (46 total cultures), and there-
fore only the initial culture result is presented in Table 2. In the
remaining three patients (2 cultures each), the original CSF cul-
ture did notmatch the subsequent CSF culture result. One patient
had Aspergillus fumigatus, followed by coagulase-negative staphy-
lococci (CoNS), one patient had CoNS followed by Propionibac-
terium acnes, and one patient had CoNS followed by Staphylococ-
cus aureus. These six culture results are reflected in Table 2. The
patient represented in both pre- and post-BBAperiods grewCryp-
tococcus neoformans at both time points.
Additionally, 83 patients had blood cultures drawn during
their hospital visit, with 25 patients having a positive blood culture
TABLE 1 Demographics and clinical characteristics of patients with
positive CSF cultures
Patient characteristica








Mean age (range) (yr) 54 (21–94) 50 (19–94) 0.22
Sex 0.11
Men 24 (49) 62 (63)
Women 25 (51) 37 (37)
Race 0.29c
White 27 (55) 64 (65)
Black 21 (43) 34 (34)
Other 1 (2) 1 (1)
Presenting symptoms
Headache 25 (51) 49 (49)
Altered mental status 24 (49) 52 (53)
Nausea/vomiting 10 (20) 20 (20)
Fever 12 (24) 15 (15)
Discharge diagnoses
Bacterial meningitis 12 (24) 8 (8)
Cryptococcal meningitis 8 (16) 9 (9)
VP shunt malfunction 3 (6) 12 (12)
Seizure disorder 1 (2) 11 (11)
Mean no. of days in hospital (range) 16 (0–85) 11 (0–86) 0.016
CNS hardware placed 17 (35) 22 (22) 0.10
Recent (within past 90 days) 14 18 0.70
Remote (90 days ago) 3 5
Surgery (past 90 days) 21 (43) 20 (20) 0.004d
Neurosurgery 19 (90) 16 (80) 0.4
Other 2 (10) 4 (20)
Immunocompromised 17 (35) 28 (28) 0.43
HIV/AIDS 8 (16) 9 (9)
Solid-organ transplant 0 3 (3)
Chronic steroids 7 (14) 8 (8)
Chemotherapy 4 (8) 10 (10)
a Unless otherwise indicated, patient characteristic data are presented as the number
(%) of subjects.
b P values in bold type are those that are statistically significant at a P value of0.05.
c “Other” race category excluded from analysis.
d The proportions of patients who underwent an operation in the pre-and post-BBA
years are significantly different, while the types of procedures between groups are not.
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result (30.1%). Sixteen of these positive results (64.0%) confirmed
the same isolate in both blood and CSF specimens: CoNS (n 1),
C. neoformans (n 6), Enterobacter aerogenes (n 2), Enterococ-
cus faecium (n 1),Klebsiella pneumoniae (n 1), S. aureus (n
2), and S. pneumoniae (n 3). Nine patients had distinct isolates
as determined from the blood and CSFmethods, and these results
are listed in Table 3.
Anaerobic culture results. Thirty-five isolates of anaerobic
bacteria were recovered during the 2-year study period. In the
pre-BBA year, 2 CSF cultures (4% of positive CSF cultures) re-
sulted in the isolation of anaerobic bacteria, both from P. acnes. In
the post-BBA year, 33 CSF cultures (32% of the positive CSF cul-
tures) were positive for the growth of anaerobic bacteria (P 
0.01). These post-BBA isolates included 15Propionibacterium spp.
isolates, 17 P. acnes isolates, and one B. thetaiotaomicron isolate.
Of note, the two P. acnes cultures from the pre-BBA year were
plated to and isolated on a BBA plate because of high clinical
suspicion due to the presence of a ventriculoperitoneal (VP) shunt
in the respective patients. All 35 anaerobic isolates grew on the
anaerobically incubated BBA. Only one isolate, a P. acnes, also
grew as pinpoint colonies on the aerobically incubated chocolate
agar.
Aerobic medium is first examined after overnight incubation,
but the BBA plate is typically not examined until it has been incu-
bated for 2 days. The growth of aerobic isolates therefore became
apparent within a median of 2 days (interquartile range [IQR], 1
to 3 days), while anaerobic isolates were noted at 3 days (IQR, 2 to
4; P 0.001). Anaerobic isolates were recovered in a similar num-
ber of patients with and without central nervous system (CNS)
hardware (22.0 versus 23.6%of positive cultures, respectively;P
0.827) and in immunocompetent and immunocompromised pa-
tients (27.2 versus 13.3% of positive cultures, respectively; P 
0.089). On the other hand, patients who had undergone a neuro-
surgical operation within 90 days of CSF culture were less likely to
have growth of anaerobic bacteria than those who had not had
surgery (6.5 versus 33.7%, respectively; P 0.002).
Clinical significance and antimicrobial therapy. Overall, pa-
tients were administered antimicrobial therapy for 46.4% (n 
70) of the isolates recovered.Of the 22 patient samples fromwhich
yeast or fungal organisms were cultured, 21 patients received
treatment; one patient expired due to other causes prior to the
CSF results becoming available. The majority of samples with
yeast or fungal isolates were from immunocompromised patients
(72.7%; P 0.001).
In a comparison of the clinical decision to treat the patient at
the time of culture with the retrospective recommendation of an
infectious diseases specialist during chart review, the agreement
was excellent (  0.94).
Factors involved in decision to treat. For the cultures with
bacterial growth, 49 patients (38%) were considered to have bac-
terial meningitis and were treated with antimicrobials accord-
ingly. Treatmentwasmore likely to be recommended if the patient
presentedwith a fever (60.0 versus 34.0%;P 0.028), had a recent
neurosurgical procedure (87.1 versus 22.1%; P 0.001), or pos-
sessed CNS hardware (72.2 versus 24.7%; P 0.001). Treatment
was less likely, however, if the patient presented with seizure ac-
tivity (21.1 versus 50.4%; P 0.025). The median CSF nucleated
TABLE 2 Isolates recovered from CSF specimen cultures
Organism








Anaerobic 2 33 0.01
Bacillus spp., not B. anthracis 0 3
Bacteroides thetaiotaomicron 0 1
Citrobacter koseri 0 1
Coagulase-negative Staphylococcus spp.
(n 50)
CoNS not otherwise specified 18 23
Staphylococcus capitis 0 1
Staphylococcus epidermidis 1 5
Staphylococcus hominis 0 1
Staphylococcus warneri 0 1
Corynebacterium spp. 1 3
Enterobacter aerogenes 2 0
Enterococcus faecalis 1 1
Enterococcus faecium 2 0
Escherichia coli 1 0
Gram-negative bacilli 3 0
Haemophilus influenzae 0 1
Klebsiella pneumoniae 0 1
Micrococcus spp. 0 3
Mixed skin microorganisms 0 1
Neisseria meningitidis, group B 0 1
Propionibacterium acnes 2 17 <0.001
Propionibacterium spp. 0 15
Pseudomonas aeruginosa 2 1
Staphylococcus aureus 2 5
Streptococcus mitis group 0 2
Streptococcus pneumoniae 5 1
Viridans group Streptococcus 0 1
Yeast/fungus (n 22)
Aspergillus fumigatus 0 1
Candida albicans 0 2
Candida parapsilosis 1 0
Candida spp. 0 1
Cryptococcus neoformans 7 9
Unspecified yeast 1 0
a P values in bold type are those that are statistically significant at a P value of0.05.
TABLE 3 Patients with discrepant blood and CSF culture resultsa





C. parapsilosis S. epidermidis
CoNS sp. not otherwise specified S. aureus
E. aerogenes Gram-negative bacillus (Gram stain
only)
P. aeruginosa Candida sp., not C. albicans
P. aeruginosa Propionibacterium acnes
Streptococcus agalactiae CoNS sp.
S. agalactiae CoNS sp.
S. mitis group CoNS sp.
a The results from each culture are shown alongside each other (e.g., an isolate defined
as Acinetobacter calcoaceticus-A. baumannii complex in blood culture was identified as
coagulase-negative staphylococci species by CSF culture).
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cell count was significantly higher in the group that received anti-
microbial therapy (704 cells/l [IQR, 25 to 1,607 cells/l]) than in
the untreated group (0 cells/l [IQR, 0 to 6 cells/l];P 0.001), as
was the CSF protein concentration (111 mg/dl [IQR, 46 to 376
mg/dl] versus 42 mg/dl [IQR, 29 to 69 mg/dl], respectively; P 
0.001) (Table 4).
For all 23 isolates (17.8%) for which an organismwas observed
ondirectGram stain of the specimen, antimicrobial treatmentwas
initiated in the patients. Of the 69 culture-positive specimens
(53.5%) with negative specimen Gram stain (i.e., no organisms,
no polymorphonuclear cells [PMN] observed), only 7 patients
were treated (P  0.001). The remaining 37 positive specimens
(28.7%) had PMN cells but no organisms seen on specimenGram
stain. These cases were almost evenly split, with 19 patients
(51.4%) receiving antimicrobial therapy and 18 patients (48.6%)
not receiving therapy. For the 49 patients fromwhomanorganism
was isolated in the CSF culture, therapy did not differ between
immunocompromised and immunocompetent patients (41.4
versus 37.1%, respectively; P 0.678).
Treatment of anaerobic bacteria. Eight patients (22.9%) with
CSF cultures growing anaerobic isolates received antimicrobial
therapy. Table 5 highlights the differences between the patients
with anaerobic isolates who received antimicrobials and those
who did not receive therapy. Patients were more likely to receive
treatment if they had CNS hardware (75.0 versus 11.1%; P 
0.001) or if they had a positive specimenGram stain with either an
organism or PMN cells (87.5 versus 22.2%; P  0.002). An in-
creased proportion of neutrophils in the CSF cell count (median,
53 versus 0% neutrophils; P 0.001) was also associated with the
decision to treat the patient. Although clinically significant isolates
seem to grow slightly faster than isolates for which patients did not
receive antimicrobial therapy (median, 2.5 versus 3 days), the dif-
ference was not statistically significant (P 0.08). Other param-
eters, such as immunocompromised state, recent surgical proce-
dure, or CSF chemistries did not play a consistent role in the
decision to treat.
Of note, two patients who received treatment did not have
CNS hardware. One patient was amanwho presentedwith altered
mental status and was found to have a pilonidal cyst. Brain mag-
netic resonance imaging (MRI) showed leptomeningeal enhance-
ment, and the patient’s CSF sample had an elevated protein (60
mg/dl) and nucleated cell count (111 cells/l), with a neutrophilic
predominance. The specimen Gram stain demonstrated poly-
morphonuclear cells and Gram-negative bacilli, and the culture
grew B. thetaiotaomicron; growth was observed on BBA in just 2
days, and metronidazole was initiated in the patient as soon as an
anaerobic pathogen was suspected. After this change in his anti-
microbial therapy, his infection cleared.
The second patient was amanwith a history ofmelanomawho
presented with alteredmental status, nausea, vomiting, and head-
ache. A head computed tomography (CT) scan showed only di-
lated ventricles, and his CSF had elevated protein (518mg/dl) and
nucleated cells (145 cells/l). A specimen Gram stain showed the
presence of polymorphonuclear cells, and 3 consecutive CSF spec-
imen cultures received over a 7-day period grew P. acnes. Despite
appropriate antimicrobial therapy, the patient was also found to
have metastatic cancer, and he eventually died as a result of this
disease (11).
DISCUSSION
The contemporary patterns of bacterial meningitis in the United
States aremarkedly different from those 30 years ago. As a result of
this epidemiologic change, clinical microbiology laboratories
must be prepared to isolate bacterial pathogens that may not his-
torically be considered common causes of bacterial meningitis. In
this study, we demonstrate that bacterial pathogens classically as-
sociated with meningitis now comprise a minority of pathogens
isolated at a tertiary care medical center. Additionally, we demon-
strate that anaerobic organisms may be clinically significant
pathogens in bacterial meningitis. By adding a single piece of me-
dium, incubated anaerobically, to our standard laboratory proce-
dure for CSF cultures, we were able to capture these clinically
relevant organisms.
Although anaerobes are often considered contaminants be-
cause they are normal flora on human skin and mucosal surfaces,
numerous case reports detail the existence and relevance of anaer-
obic organisms in bacterial meningitis (12–21). These reports
highlight some of the predisposing factors for anaerobic menin-
TABLE 4 Analysis of CSF specimens with bacterial growth
CSF analyte
Median (IQR) values by
antimicrobial treatment status
PbTreateda Untreated
Nucleated cells (cells/l) 704 (25, 1,607) 0 (0, 6) 0.001
Neutrophils (%) 78 (21, 88) 2 (0, 17) 0.001
Lymphocytes (%) 8 (2, 18) 65 (33, 81) 0.001
Protein (mg/dl) 111 (46, 376) 68 (29, 69) 0.001
Glucose (mg/dl) 23 (20, 68) 68 (55, 77) 0.001
a Treated, indicates that these patients were treated with appropriate antimicrobials
after the culture results had been finalized.
b All P values are significant at0.05.
TABLE 5 Evaluation of patients with isolation of anaerobic isolates who









Fever (n [%]) 1 (12.5) 1 (3.7) 0.41
CNS hardware (n [%]) 6 (75.0) 3 (11.1) 0.001
Immunocompromised (n [%]) 1 (12.5) 5 (18.5) 0.9
Neurosurgery within 90 days (n [%]) 2 (25.0) 1 (3.7) 0.124
No. with specimen Gram stain 0.002b
Organism detected 5 0
PMN (no organism) 2 6
Negative (no organism, no PMN) 1 21
No. of CSF nucleated cells/l
(median [IQR])
58 (0, 364) 0 (0, 5) 0.088
% neutrophils (median [IQR]) 53 (22, 91) 0 (0, 5) <0.001
CSF protein (median [IQR]) (mg/dl) 70 (25, 176) 36 (25, 56) 0.323
CSF Glucose (median [IQR]) (mg/dl) 20 (11, 76) 65 (60, 73) 0.096
Single isolate growth 7 (87.5) 25 (92.6) 0.553
Days of incubation for detection
(median [IQR])
2.5 (0.8–4.3) 3.0 (1–5) 0.08
a P values in bold type are those that are statistically significant at a P value of0.05.
b P value calculated for negative Gram stain versus organism/PMN on Gram stain.
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gitis, such as infection (otitis media or upper respiratory infec-
tions), trauma, a recent surgical procedure, or the presence of
CNS hardware, in particular a ventriculoperitoneal shunt (14).
These reports also emphasize the fact that in a symptomatic pa-
tient with aCSF pure culture of the organism, it is unlikely that the
anaerobic organism is a mere contaminant (13). Still, because an-
aerobes require specific growth conditions not routinely provided
for CSF specimens, the true incidence of anaerobic bacterial men-
ingitis remains unknown.
In our study population, approximately one-third of all organ-
isms isolated from CSF specimens after the addition of the bru-
cella blood agar were anaerobic bacteria. A subset of these anaer-
obes were considered clinically significant, and the patients were
treated with antimicrobial therapy plus shunt revision where ap-
propriate. In patients with a CNS shunt, the presence of anaerobic
bacteria in the CSF has been associated with low-grade infection
that resolves upon exchange of the shunt (18, 22). Additionally,
early recognition of shunt infection and subsequent replacement
can decrease expensive repeat hospitalizations, infectiousworkup,
and unnecessarily broad antimicrobial treatment.
Anaerobicmeningitis is not limited to patients with CNS hard-
ware, and two of our study patients with CSF anaerobic isolates
did not have a shunt or a history of a recent neurosurgical proce-
dure. Although these represent only two cases of community-ac-
quired anaerobic meningitis from a total of 2,302 cultures, the
importance of recovering anaerobes from CSF specimens cannot
be overstated. Prompt recovery of a pathogen, if present, can ex-
pedite appropriate treatment and minimize additional medical
interventions and/or diagnostic studies. Anaerobic bacteria re-
main highly susceptible to antimicrobials, meaning that discovery
of an anaerobic pathogen can allow for streamlining of antimicro-
bial therapy (14).
The purchase of BBA and an increase in labor time are labora-
tory costs that were considered with the institution of this proto-
col. The addition of a BBA plate can be quite easily incorporated
into the existing laboratory procedure for the culture of CSF spec-
imens. The cost of the additional medium is approximately $4.00
per specimen,making this an inexpensive intervention.Due to the
relatively low growth rate of anaerobic bacteria, an extended in-
cubation time for the BBA is necessary; in this study, 80% of all
anaerobes recovered had been isolated within the first 4 days. No
plates were incubated for6 days, and thus we lack data to pro-
mote or refute prolonged incubation of CSF cultures. Although
increased incubation times may marginally increase laboratory
costs, this cost may be outweighed by cost savings at a hospital
level due to timely pathogen identification and appropriate anti-
microbial therapy, not to mention the benefit to the patient. At a
minimum, we recommend that patients with CNS hardware have
an anaerobic component to their CSF culture, although the com-
munity-acquired anaerobic meningitis cases highlight the impor-
tance of taking an unbiased approach to the addition of the BBA
medium.
The anaerobic isolates in our population were found to be
Propionibacterium spp. orP. acnes, with the exception of a singleB.
thetaiotaomicron isolate. It is well known that Propionibacterium is
a component of the normal skin flora and thatP. acnes is especially
prevalent on areas of skin with a high density of sebaceous glands,
such as the scalp (23). For this reason, teasing out true infection
versus a contaminated culture can be a difficult task for clinicians.
As this study shows, the decision to treat a patient with antimicro-
bials is complex and based only in part on the result of a CSF
culture. Clinicians take into account patient history and present-
ing symptoms, with special emphasis placed on the results of CSF
studies, including direct specimen Gram stain, protein and glu-
cose concentrations, nucleated cell count, and the relative per-
centage of neutrophils identified (12, 13).
This study has several strengths. By evaluating 2 years worth of
laboratory and clinical data, we were able to present a detailed
view of the isolates attributed to bacterial meningitis in the post-
vaccination era at an academic medical center. The clinical data
collected on each patient were extensive, and the inclusion of an
infectious diseases specialist on our study team allowed for the
most accurate evaluation possible of the clinical significance of
each isolate recovered from the CSF specimens. That being said,
this study is not without limitations. As with any retrospective
study, the data collected may be incomplete, and it is difficult to
evaluate the clinical significance of any one laboratory isolate with
a chart review. Because separate physician orders for aerobic and
anaerobic bacterial CSF cultures do not exist within our system,
we cannot comment on clinical suspicion of anaerobic meningitis
prior to the routine addition of BBA to CSF cultures. This study
was conducted at a large tertiary care academicmedical center and
thus may not be reflective of other care settings. Additionally, our
laboratory serves an adult population only. Children, and neo-
nates especially, have a distinct set of risk factors that alter the
microbes implicated in pediatric bacterial meningitis, and our
data cannot be extrapolated to the pediatric population. Finally,
although we had large numbers of CSF specimens submitted for
culture, the number of positive results over the 2-year study pe-
riod remained relatively small.
The results of this study highlight the change in the contempo-
rary epidemiology of bacterial meningitis in the United States.
Our results demonstrate that the simple inexpensive addition of
an anaerobically incubated BBA plate to the CSF culture protocol
aids in the recovery of clinically significant anaerobic isolates from
CSF specimens. The patients withmeningitis from anaerobic bac-
teria are not limited to patients with CNS hardware or to immu-
nosuppressed patients. In 1998, Sabeen Askari and Charles Cart-
wright noted (24):
The clinical consequences of bacterial infection of the cen-
tral nervous system guarantee that the diagnosis of such
infections will remain a high priority for clinicians and
laboratorians alike. In the face of a disease whose epidemi-
ology continues to change, it seems likely that periodic re-
assessments of how best to make a diagnosis of bacterial
meningitis will be necessary.
This observation still holds true today.
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